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Aims Problems with implanting a left ventricular (LV) lead during cardiac resynchronization therapy (CRT) procedures are
not uncommon and may occur for a variety of reasons including phrenic nerve stimulation (PNS) and high capture
thresholds. We aimed to perform successful CRT in patients with previous LV lead problems using the multiple




Four patients with previous failed attempts at LV lead implantation underwent a further attempt at CRT using a Quartet
lead. In all four cases, successful CRT was achieved using a Quartet lead placed in a branch of the coronary sinus. Pro-
blems with PNS or high capture thresholds were seen in all four patients but were successfully overcome. Satisfactory
lead parameters were seen at implant, pre-discharge, and at short-term follow-up (8.5+5 weeks).
Conclusion The Quartet lead allows 10 different pacing vectors to be used and may overcome common pacing problems because
of the multiple pacing conﬁgurations available. Problems with either PNS or unsatisfactory pacing parameters experi-
enced during CRT may be resolved simply by changing the pacing conﬁguration using this quadripolar lead system.
-----------------------------------------------------------------------------------------------------------------------------------------------------------
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Introduction
Cardiac resynchronization therapy (CRT) improves heart failure
symptoms and reduces hospitalizations and risk of death in
patients with left ventricular (LV) dysfunction and a broad
QRS.
1–3 Failure to implant an LV lead during attempted CRT
occurs in  5–15% of cases.
4–6 This may be because of an
inability to cannulate the coronary sinus (CS) ostium, an inability
to pass the LV lead into a CS branch, unsatisfactory pacing par-
ameters, or phrenic nerve stimulation (PNS). In a study of 197
consecutive patients undergoing CRT, Bifﬁ et al. showed that
clinically relevant PNS occurred in 22% of patients at CRT
implant or follow-up and that its occurrence was highest in
those patients for whom the LV lead was placed at pacing sites
most associated with reverse remodelling. In the aforementioned
study, 7% of patients required an LV lead revision or CRT to be
turned off and cathodal programmability (the capability to
program either the proximal or the distal LV lead electrode as
cathode) was described as a possible solution to the problem
of PNS.
7 Indeed, other studies
8,9 have shown that the availability
of multiple pacing conﬁgurations may overcome problems with
high pacing capture thresholds and PNS.
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doi:10.1093/europace/eur032The Quartet LV lead model 1458Q (St Jude Medical, Sylmar,
CA, USA) is a multipolar LV lead with three ring electrodes in
addition to the tip electrode. The three ring electrodes are
located 20, 30, and 47 mm from the tip that has a 4.0 Fr diameter.
The maximum lead body diameter is 4.7 Fr and the lead is easily
manoeuvrable. The Quartet lead allows all four of the electrodes
on the lead to act as the cathode and two also as an anode. In
addition, the right ventricular (RV) coil of the shocking lead
may act as an anode thus giving 10 possible bipolar and unipolar
pacing conﬁgurations (see Figure 1). Theoretically, a change in
pacing vector may allow problems not only with PNS to be over-
come but also with unsatisfactory pacing capture thresholds. In
the temporary setting, Thibault et al.
10 reported that problems
with PNS could be overcome with ‘electronic repositioning’ of
the Quartet lead by changing the pacing vector. Forleo et al.
11
have compared the Quartet lead with conventional bipolar
leads and found it to be associated with a reduced need for
lead revision or reprogramming. We report a series of four
patients, all of whom had previously had a failed LV lead implan-
tation attempt and who went on to have successful CRT using a
Quartet lead.
Methods
Four patients, two males and two females with mean age 55+21
years, underwent re-attempt at LV lead implantation at our insti-
tution between March and May 2010 (see Table 1). All the four
patients had New York Heart Association (NYHA) class III symp-
tomsofheartfailureofanon-ischaemicaetiology.Themeanleftven-
tricularejectionfraction(LVEF)was28+8.7%priortoreattemptat
LV lead implantation. Three patients were in sinus rhythm and one
was in atrial ﬁbrillation. In our institution, we aim to place the LV
lead in an optimal CS vein for resynchronization and this usually
means a postero-lateral or lateral position. In these four difﬁcult
cases, the main determinant of LV lead position was a pacing con-
ﬁguration that gave the best pacing parameters (lowest capture
threshold with good R-wave) without PNS.
Results
Inallfourcases,aPacesetterSt.JudeQuartetleadmodel1458Qand
Promote Q Model CD3221-36 generator (St Jude Medical) were
Figure 1 Ten vectors are available using the three ring electro-
des and distal tip of the Quartet lead and the RV coil: 1. distal 1
(D1) to mid 2 (M2); 2. D1 to proximal 4 (P4); 3. D1–RV coil; 4.
M2–P4; 5. M2–RV coil; 6. mid 3 (M3) to M2; 7. M3–P4; 8.
M3–RV coil; 9. P4–M2; and 10. P4–RV coil (image courtesy of
St Jude Medical).
...............................................................................................................................................................................
Table 1 Patient characteristics pre-Quartet lead implant





1 72 F Sinus rhythm;
LBBB; QRSd
140 ms
III 25 Non-ischaemic Two previous attempts at CRT with two different bipolar
leads but PNS or high capture thresholds in all target veins
2 60 M Sinus rhythm;
LBBB; QRSd
160 ms
III 20 Non-ischaemic Previous attempt at CRT in referring center but implanter
unable to pass guide catheter into CS. Onlyone suitable CS
vein found at our center but PNS seen using conventional
bipolar lead
3 24 M AF; LBBB
(paced);
QRSd 160 ms
III 20 Non-ischaemic Previous AVSD repair and dual-chamber pacemaker for severe
sinus and AV node disease. At CRT-P upgrade only two
suitable veins seen and PNS found in one of these. LV lead
placed in the other CS branch (without PNS at implant) but
PNS found at follow-up and LV lead switched off
4 64 F Sinus rhythm;
LBBB; QRSd
170 ms
III 35 Non-ischaemic One previous attempt at CRT with two different bipolar leads
but PNS or high capture thresholds in all target veins
M ¼ male; F ¼ female.
Use of a quadripolar left ventricular lead 993successfully implanted. The mean procedure time for the four cases
was 157.5+42.1 min. The ﬂuoroscopy time was 18.2+19.8 min
witharadiationdoseof1178+1417.2 cGy cm
2.Pacingparameters
were stable at pre-discharge pacing check and latest follow-up of
8.5+5 weeks (see Table 2).
Case 1
A 72-year-old female with a non-ischaemic cardiomyopathy, LVEF
of 25%, left bundle branch block (LBBB), QRS duration (QRSd)
140 ms, and NYHA class III symptoms of heart failure was referred
to our centre for consideration of an epicardial surgical approach
to LV lead placement following two previous failed transvenous
attempts at CRT. The referring centre had cannulated all possible
target veins during the two previous attempts at LV lead place-
ment, but PNS or unsatisfactory pacing parameters were found
in all branches using Attain Ability 4196 (Medtronic Inc., Minneapo-
lis, MN, USA) and Easytrak 2 (Boston Scientiﬁc Corp., Natick, MA,
USA) LV leads. The patient elected to have a further attempt at
trans-venous LV lead implantation at our institution before consid-
ering an epicardial surgical approach.
We placed a Quartet lead via the left subclavian vein in pos-
terior, lateral, postero-lateral and antero-lateral branches of the
CS. High capture thresholds or PNS were found in all CS branches.
The lead was ﬁnally positioned in a lateral branch with a capture
threshold of 1.75 V at 0.8 ms pulse width (3.75 at 0.5 ms pulse
width) and an impedance of 950 V using the vector from the
distal tip of the LV lead to the coil of the RV shocking lead,
vector D1–RV coil (see Figure 2). A new Pacesetter St Jude
Durata model 7122 (St Jude Medical) shocking lead was placed
in the RV apex. The old pace/sense lead was capped and the
three remaining leads attached to a Promote Q Model
CD3221-36 generator that was placed in a subcutaneous pocket.
Pre-discharge capture thresholds for the 10 possible pacing
vectors were tested at a pulse width of 0.5 ms—D1–M2: 1.25 V;
D1–P4: 1.0 V; D1–RV coil: 1.0 V; M2–P4: 7 V; M2–RV coil:
5.25 V; M3–M2: no capture; M3–P4: no capture; M3–RV coil:
no capture; P4–M2: no capture; and P4–RV coil: no capture.
The large range of thresholds seen here using different pacing con-
ﬁgurations may be because of differing levels of contact between
each lead pole and the surrounding tissue. Variations in pacing
parameters between different poles may also be caused by
varying levels of tissue ﬁbrosis or scar.
At latest follow-up, 16-week post-implant, the patient was
symptomatically much improved in NYHA class I and her LVEF
had improved to 50%. Her latest pacing check at 16-week post-
implant showed that the threshold on the LV lead was 1.25 V at
0.5 ms pulse width with an impedance of 1300 V.
Case 2
A 6o-year-old male with non-ischaemic cardiomyopathy, LBBB
(QRSd 160 ms), LVEF 20%, and NYHA class III dyspnoea was
referred to our centre for a further attempt at LV lead implant.
Cannulation of the CS had proved difﬁcult at the referring
centre and although the implanter was able to place a 0.032 in.
diameter terumo wire (Terumo Medical Corp., Somerset, NJ,
USA) into the CS, he was unable to pass three different guide cath-
eters over the wire. As the patient had received over 25 min of
ﬂuoroscopy, a dual-chamber CRT-D was left in situ (St Jude
Medical Promote RF Model 3213-36 generator, Pacesetter St
Jude Durata 7120 shocking lead in the RV apex and Pacesetter
St Jude Tendril ST 1888TC in the right atrial appendage) and the
LV port was plugged. The implanter felt that there may have
been a Thebesian valve at the CS ostium hindering cannulation
................................................................................
Table 2 Pacing parameter data
Pacing parameter
Mean implant LV capture threshold at 0.5 ms pulse
width
2.0+1.6 V
Pre-discharge LV capture threshold at 0.5 ms pulse
width
1.4+0.7 V
LV capture threshold at latest (8.5+5 weeks)
follow-up at 0.5 ms pulse width
1.3+0.2 V
LV lead impedance at implant 1057+254 V
Pre-discharge LV lead impedance 912.5+394 V
LV lead impedance at latest (8.5+5 weeks)
follow-up
872+387 V
Figure 2 (A) Right anterior oblique projection of balloon
occlusive venogram shows multiple coronary sinus (CS) branches
available. (B) Posterior–anterior view of the ﬁnal Quartet lead
position in a high lateral branch of the CS.
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transvenous LV lead implant followed by a surgical approach if
unsuccessful.
At our centre, the CS was successfully cannulated and a St Jude
Quicksite Model 1056 LV lead passed into a posterior branch of
the CS. Phrenic nerve stimulation was seen, however. As this
was the only suitable vein, we removed the LV lead and replaced
it with a Quartet lead to take advantage of the multiple vectors
available to overcome PNS. The Quartet lead was placed in a
similar position to the discarded LV lead but satisfactory pacing
parameters (threshold 0.75 V at 0.5 ms; impedance 740 V) and
no PNS was found when pacing using the M3–M2 vector.
Six weeks later, the patient’s LVEF had improved to 35–40% and
symptomatically he was in NYHA class II. Left ventricular lead par-
ameters were stable (threshold 1.5 V at 0.5 ms, impedance 850 V).
The QRSd on electrocardiogram (ECG) had reduced to 104 ms.
Case 3
A 24-year-old male with a previous history of a partial atrioventri-
cular septal defect (AVSD) repair, severe sinus, and AV node
disease with left bundle branch block had previously had a dual-
chamber pacemaker implantation 10 years earlier. This was
upgraded to a CRT-P device 5 years later as he was found to
have a non-ischaemic cardiomyopathy and NYHA class III symp-
toms. He developed persistent atrial ﬁbrillation 2 years ago and
suffered a stroke. He was admitted with worsening heart failure
and found to have intermittent PNS even with a low LV lead
output (2.5 V). The LV lead was therefore programmed off and
he was listed for extraction of the lead with re-implant of a new
LV lead and RV shocking lead. His echocardiogram pre-procedure
conﬁrmed an LVEF of 20% with moderate–severe mitral regurgita-
tion and moderate tricuspid regurgitation. At his device upgrade
5 years previously, it had been noted that he had PNS in the
only other vein suitable for an LV lead. It was therefore decided
that the re-implant should be with a Quartet lead to overcome
any potential problems with PNS (see Figure 3).
The original LV lead (Medtronic Attain model OTW 4193) was
successfully extracted and a new Pacesetter St Jude Durata model
7120 shocking lead placed in the RV apex. A Quartet lead was
positioned in the postero-lateral branch of the CS that was not
used 5 years earlier because of PNS. Phrenic nerve stimulation
was again found in this CS tributary when pacing using convention-
al bipolar LV pacing (D1–M2 vector). The problem was overcome,
however, with a switch to the M3–M2 vector (threshold 0.5 V at
0.5 ms pulse width, impedance 997 V). The old RV pace/sense lead
(Medtronic Viatron model IMD 49B) and atrial lead (Medtronic
Viatron model IMX 49 JB) were capped and the remaining leads
attached to a Promote Q model CD3221-36 generator placed in
a new sub-pectoral pocket.
Lead parameters were stable at pre-discharge pacing check
and at 6-week follow-up (threshold 1 V at 0.5 ms pulse width;
impedance 1100 V). His LVEF was found to have improved to
40–45% at this time.
Case 4
A 64-year-old female with non-insulin-dependent diabetes, non-
ischaemic cardiomyopathy, and previous history of hypertension
and stroke was found to have non-sustained ventricular tachycardia
on Holter monitoring, LBBB (QRSd 170 ms), LVEF 35%, and
NYHA class III symptoms underwent attempted CRT. A Medtronic
Attain Ability model 4196 LV lead was placed in a high lateral CS
branch but a high pacing capture threshold was found. The implan-
ter was unable to pass the lead into a lower (small) lateral branch
and the middle cardiac vein had PNS distally with no capture when
pulled more proximally. This LV lead was discarded and a St Jude
QuickSite model 1056T LV lead was placed in the middle cardiac
vein but a capture threshold .5 V was found distally and again
no capture proximally. It was not possible to pass this lead into
the high lateral branch. This lead was also discarded and no
further attempts at LV lead implantation were made on this
occasion. A Pacesetter St Jude Tendril model 1788T atrial lead
was placed in the right atrial appendage and a Pacesetter St Jude
Durata model 7120 was placed in the RV apex.
The patient returned to our institution 9 months after the orig-
inal attempt at CRT for a further attempt at LV lead placement. A
Quartet LV lead was successfully implanted in a postero-lateral
branch of the CS (vector D1–M2; capture threshold 3.1 V at
0.5 ms pulse width; impedance 1344 V). The lead was attached
to a Promote Q model CD3221-36 generator and placed in the
old pre-pectoral pocket. Pacing parameters had improved at pre-
discharge pacing check (threshold 1.75 V at 0.5 ms pulse width,
Figure 3 (A) Left anterior oblique view of coronary sinus (CS)
balloon occlusion venogram showing original left ventricular lead
position and target branch for quartet lead. (B) Posterior–
anterior view of ﬁnal quartet lead position in the postero-lateral
branch of CS.
Use of a quadripolar left ventricular lead 995impedance 510 V) and were better still at 6-week pacing check
(threshold 1.25 V at 0.5 ms, impedance 540 V).
Discussion
We have demonstrated that the Quartet lead can be implanted
successfully in patients who have previously had failed attempts
at LV lead placement. We have also shown that problems with
PNS and high capture thresholds can be overcome simply by chan-
ging the pacing vector. Our short-term follow-up data on this small
cohort of patients suggest that the Quartet lead pacing parameters
remain satisfactory at pre-discharge and at latest follow-up.
A signiﬁcant number of patients are found to have PNS or unsa-
tisfactory LV lead parameters at CRT implant or during follow-up.
Indeed, as PNS may be posture dependent and thus not manifest at
implantation, it may be an underreported complication. Tech-
niques for overcoming PNS include reducing the LV pacing
output, repositioning the LV lead, surgical placement of an epicar-
dial LV lead, or turning off LV pacing altogether. Cathodal program-
mability offers an excellent non-invasive alternative solution to the
problem.
Several LV leads offer cathodal programmability and thus the
ability to change pacing vector if conventional bipolar LV pacing
is not satisfactory. The Quartet LV lead with an appropriate
CRT device has the ability to pace from any of its four LV lead elec-
trodes as cathode. Anode choices include two LV electrodes as
well as the RV coil thus giving 10 possible pacing conﬁgurations.
The use of bipolar leads that allow the pacing conﬁguration to
be altered if problems occur with PNS or high capture thresholds
may resolve these problems without the need to resort to high LV
pacing outputs, lead repositioning, or surgical approaches to LV
lead placement. Indeed, in our case series, the programmability
of the quartet lead obviated the need for an epicardial surgical
approach to CRT in at least two patients.
The advantage of the Quartet lead over other leads with cath-
odal programmability is the number of vectors available. Thus, if
problems with PNS or high capture thresholds are encountered,
it offers more pacing conﬁgurations than other CRT systems and
may allow patients with previous failed attempts at LV lead
implantation the potential to have a successful transvenously
placed LV lead rather than the options of either an epicardial
surgical approach to CRT or no CRT at all. In this study, the
M3–M2 vector used as the ﬁnal conﬁguration in two of our
patients is not available with other bipolar LV leads but the
D1-M2 and D1-RV coil vectors used in the other two patients
can be programmed with other CRT systems. The fact that we
were also successful in these cases using conventional bipolar
conﬁgurations suggests that the handling characteristics and
lead geometry of the Quartet lead may have allowed us to
attain a position in the CS that was different from the bipolar
leads previously used.
This study is limited by its small size, non-randomized nature,
and lack of control group. Further studies looking at how different
pacing conﬁgurations affect dyssynchrony indices and LV volumes
are required.
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